Concepedia

Holly Fisher

HF

Statistics

Publications

9

Citations

430

H-Index

9

Active since

2018

Affiliations

Newcastle University(Current)

Newcastle upon Tyne Hospitals NHS Foundation Trust

Cambridge University Hospitals NHS Foundation Trust

University of Cambridge

University of Birmingham

Holly Fisher is an author at Newcastle University specializing in cholangiopathies, medicine, and primary sclerosing cholangitis.

ORCID

Top concepts

Publications per year

2018–2024

9

Publications

9

Continuous low-dose antibiotic prophylaxis for adults with repeated urinary tract infections (AnTIC): a randomised, open-label trial

Holly Fisher, Yemi Oluboyede, Thomas Chadwick et al. · The Lancet Infectious Diseases · 2018 · 106 citations · Full text

Greater Transplant-Free Survival in Patients Receiving Obeticholic Acid for Primary Biliary Cholangitis in a Clinical Trial Setting Compared to Real-World External Controls

Carla Fiorella Murillo Perez, Holly Fisher, Shaun Hiu et al. · Gastroenterology · 2022 · 91 citations · Full text

Pruritus Is Common and Undertreated in Patients With Primary Biliary Cholangitis in the United Kingdom

Vinod S. Hegade, George Mells, Holly Fisher et al. · Clinical Gastroenterology and Hepatology · 2018 · 76 citations

, , +6

The Impact of Autoimmune Hepatitis and Its Treatment on Health Utility

Lin Lee Wong, Holly Fisher, Deborah Stocken et al. · Hepatology · 2018 · 75 citations · Full text

Continuous low-dose antibiotic prophylaxis to prevent urinary tract infection in adults who perform clean intermittent self-catheterisation: the AnTIC RCT

Robert Pickard, Thomas Chadwick, Yemi Oluboyede et al. · Health Technology Assessment · 2018 · 31 citations · Full text

1–5 of 9